Please login to the form below

Not currently logged in
Email:
Password:

Allergy Therapeutics

This page shows the latest Allergy Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

Meanwhile UK biotech company Allergy Therapeutics has some good news at last from its long-delayed allergy treatment.

Latest news

  • Positive mid-stage trial gives Allergy’s investors some welcome relief Positive mid-stage trial gives Allergy’s investors some welcome relief

    Allergy Therapeutics’long-stalled efforts to develop a grass pollen allergy candidate finally seem to have lurched into motion, with a positive phase II trial setting up registration trials next year. ... This study represents a major milestone in our

  • Nestlé Health Science invests $145m in food allergy biotech Nestlé Health Science invests $145m in food allergy biotech

    Nestlé Health Science invests $145m in food allergy biotech. Aimmune Therapeutics' lead product is a phase III peanut allergy treatment. ... An oral biologic containing the protein profile found in peanuts, AR101 is designed to desensitise patients with

  • Consilium wins Allergy Therapeutics account Consilium wins Allergy Therapeutics account

    Consilium wins Allergy Therapeutics account. Will advise the firm on international investor relations. ... Consilium Strategic Communications has been appointed by specialty pharmaceutical firm Allergy Therapeutics as its international investor relations

  • Leaning forward

    Leaning forward. Allergy Therapeutics used lean management tools to make their Odyssey of improvement. ... Allergy Therapeutics develops, manufactures and sells a range of pharmaceutical products for the treatment and prevention of allergy.

  • Yo-yoing

    Shares in Allergy Therapeutics, a specialist pharmaceutical company that focuses on allergy vaccination, benefited from news that it has achieved a positive outcome for its key clinical efficacy and safety study ... R204, which marks an important step in

More from news
Approximately 2 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Deal Watch table for August 2014 Deal Watch table for August 2014

    587.5. Santaris/ Roche (pRED). Company acquisition. Locked Nucleic Acid (LNA) platform for RNA-targeting therapeutics. ... 183. Immune Design/ Sanofi. Licence. GLAAS discovery platform to develop therapeutics for a selected food allergy.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    Allergy Therapeutics - Allergy products. CSL Behring - Corporate, Critical care, Immunology.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics